Partnering with Pfizer

The Partner of Choice

Today's Pfizer is moving beyond a reliance on a few blockbuster medicines to a more diversified portfolio. Pfizer has clear strategies and business units accountable for them, creating a company marked by accountability, speed, agility and keeping commitments to stakeholders. At Pfizer we are committed to fill lives with more years and years with more life.

Partnerships are an integral part of our history and fundamental to everything we do. We share your vision for bringing innovative products to patients around the world. Pfizer's goal is to become the preferred partner of choice.

We're interested in working with a wide range of partners, in all phases of scientific and technical development throughout the world, including:

• Biotechs
• Pharmaceutical Companies
• Academic Researchers and Institutions
• Innovators in Healthcare Services or Technologies

Our approach to collaboration is simple: Together, we can provide genuine value for patients and partners. From the beginning, we are interested in exploring ways to work together that advance the goals of each of our organizations, and we're committed to ensuring that open communication, transparency and flexibility are at the core of every partnership.

A Shared Vision

We have an experienced and dedicated business development team to evaluate and execute acquisitions, partnerships, in-licensing and out-licensing in Primary Care, Specialty Care, Oncology, Emerging Markets, Established Products, Diversified Businesses and Research & Development.

We welcome opportunities for collaboration in all phases and areas of scientific and technical development including:

• Biologics
• Vaccines
• Small Molecules
• Technologies

We hope you'll take a few minutes to learn more about us — and find out how we can work together for a healthier world.

• Submit an inquiry